A recent study suggests that as many as one-third of all knee replacement surgeries may be unnecessary. This brings into question the validity of the growing number of Zimmer knee replacement complications that have been reported in recent years. The study indicates that a concerning... Read More

A new study has revealed another side effect risk associated with the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy. Researchers at McMaster University have discovered that use of SSRIs during pregnancy could increase the risk of childhood diabetes and obesity. This new finding... Read More

A group of physicians has come together to dispute requests for warning labels on products to treat low testosterone levels or “low-T.” The Androgen Study Group was created by doctors to fight a move by consumer advocate group Public Citizen, which has petitioned the FDA... Read More

Endo International PLC, the parent company of American Medical Systems, has agreed to settle thousands of AMS mesh lawsuits filed by women who allege serious injuries from the devices. The company plans to pay out around $830 million in settlement monies, which Endo claims will... Read More

A new study from the University of Maryland found that off-label Risperdal use in youth may be linked more closely to socioeconomic status than sound medical practice. Researchers discovered an unusually high proportion of children in foster care taking Risperdal to treat ADHD. Findings raise... Read More

As federal coordination of Zimmer NexGen knee lawsuits continues to grow, attorneys for the plaintiffs and defendants have requested coordination of state litigation as well. The joint update filed on March 10 requested that the federal MDL establish a “relationship of coordination” with state cases... Read More

A new study by researchers in Finland may put to rest worries over metal-on-metal hip implants and a higher overall risk of cancer, at least in the short term. However, scientists warned that risk for other types of Zimmer hip complications is still a concern.... Read More

Bayer has indicated it intends to provide thousands of Yaz settlements to plaintiffs with cases currently pending in the United States. According to the company’s 2013 Annual Report, Bayer plans to spend approximately $1.69 billion to settle lawsuits alleging blood clots and other venous disorders,... Read More